Inhibition of T24 and RT4 Human Bladder Cancer Cell Lines by Heterocyclic Molecules
Zhi-Feng Zhao1, Kai Wang1, Feng-Fu Guo1
1Department of Urinary Surgery, Linyi People's Hospital, Linyi, Shandong, China (mainland).
Abstract:
BACKGROUND Bladder cancer is a major widespread tumor of the genitourinary tract. Around 30% of patients with superficial cancers develop invasive and metastatic pathology. MATERIAL AND METHODS Some new heterocyclic 4-methyl coumarin derivatives were designed using molecular modeling studies to evaluate their potential against bladder cancer lines T24 and RT-4. The designed compounds that showed good binding affinity to T24 and RT4 were synthesized, with excellent yield. The synthesized compounds after structural evaluation were further evaluated for their antiproliferative activity by cell viability assay, cell cycle analysis, and apoptosis assay. RESULTS The compound BC-14 exhibited the best cytotoxicity against T24 cells, but were not highly active against RT4 cells. CONCLUSIONS The results of the present study may suggest the selectivity pattern of the synthesized compounds. These results should be explored further with chemical modification for other cancer types.
Insights
New heterocyclic coumarin derivatives show potential against bladder cancer. Compound BC-14 demonstrated significant cytotoxicity against T24 cells, suggesting selective anti-cancer activity for further exploration.
Area of Science:
- Medicinal Chemistry
- Oncology
- Drug Discovery
Background:
- Bladder cancer is a prevalent genitourinary malignancy.
- A significant portion of superficial bladder cancers progress to invasive or metastatic disease.
Purpose of the Study:
- To design and synthesize novel heterocyclic 4-methyl coumarin derivatives.
- To evaluate the antiproliferative potential of these compounds against bladder cancer cell lines T24 and RT-4.
Main Methods:
- Molecular modeling was employed for compound design.
- Synthesized compounds underwent structural verification.
- Antiproliferative activity was assessed using cell viability, cell cycle, and apoptosis assays.
Main Results:
- Compound BC-14 displayed potent cytotoxicity against T24 bladder cancer cells.
- The synthesized compounds showed varying activity profiles against T24 and RT-4 cell lines.
Conclusions:
- The study highlights a selective cytotoxicity pattern among the synthesized coumarin derivatives.
- Further investigation with chemical modifications is warranted for broader anti-cancer applications.
